{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "db0e2c64",
   "metadata": {},
   "source": [
    "# Compare self-trained models"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6deff760",
   "metadata": {},
   "source": [
    "## Compare models on training dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "f1632d86",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "os.environ[\"HF_HUB_DISABLE_SYMLINKS_WARNING\"] = \"1\" # suppresses Huggingface warning of storing data rather than symlinking it\n",
    "from transformers import AutoTokenizer, AutoModelForPreTraining, pipeline\n",
    "\n",
    "import sys\n",
    "sys.path.append('../../')\n",
    "# load functions for import of clinicaltrials.gov data written previously\n",
    "from app.data.loader import load_trials_json, extract_from_clinicaltrials\n",
    "from app.nlp.pipelines import load_ner_trained_pipeline\n",
    "from app.nlp.utils import * # custom functions required for NER and summarization\n",
    "from app.nlp.evaluate_model import elements_from_cell, substring_partial_overlap, evaluate_ner_model_partial_overlap, measure_processing_time, calculate_batch_throughput\n",
    "from rouge_score import rouge_scorer # library for ROUGE score calculation\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "e93e50ca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "             model  training_time  inference_time  eval_loss  eval_precision  \\\n",
      "0  compact-biobert        1778.84           23.86   0.005030        0.990808   \n",
      "1   bio-mobilebert        1638.39           23.34   0.004630        0.985845   \n",
      "2     biobert-v1.1        3492.89           44.67   0.002542        0.996172   \n",
      "\n",
      "   eval_recall   eval_f1  eval_runtime  eval_samples_per_second  \\\n",
      "0     0.991948  0.991378       23.8608                   64.835   \n",
      "1     0.988113  0.986978       23.3364                   66.291   \n",
      "2     0.997699  0.996935       44.6654                   34.635   \n",
      "\n",
      "   eval_steps_per_second  epoch  \n",
      "0                  8.131    3.0  \n",
      "1                  8.313    3.0  \n",
      "2                  4.343    3.0  \n"
     ]
    }
   ],
   "source": [
    "# data extracted during training on colab, listed are metrics on test dataset\n",
    "train_results_cb = {'model':'compact-biobert','training_time':1778.84,'inference_time': 23.86, 'eval_loss': 0.005029556341469288, 'eval_precision': 0.9908081194944466, 'eval_recall': 0.9919478527607362, 'eval_f1': 0.9913776585552788, 'eval_runtime': 23.8608, 'eval_samples_per_second': 64.835, 'eval_steps_per_second': 8.131, 'epoch': 3.0}\n",
    "train_results_mb = {'model':'bio-mobilebert','training_time':1638.39,'inference_time': 23.34, 'eval_loss': 0.004630366340279579, 'eval_precision': 0.9858454475899006, 'eval_recall': 0.9881134969325154, 'eval_f1': 0.9869781692837993, 'eval_runtime': 23.3364, 'eval_samples_per_second': 66.291, 'eval_steps_per_second': 8.313, 'epoch': 3.0}\n",
    "train_results_bb = {'model':'biobert-v1.1','training_time':3492.89,'inference_time': 44.67, 'eval_loss': 0.002541647059842944, 'eval_precision': 0.9961715160796325, 'eval_recall': 0.9976993865030674, 'eval_f1': 0.9969348659003832, 'eval_runtime': 44.6654, 'eval_samples_per_second': 34.635, 'eval_steps_per_second': 4.343, 'epoch': 3.0}\n",
    "\n",
    "\n",
    "# Create a DataFrame\n",
    "df_traing = pd.DataFrame([train_results_cb, train_results_mb, train_results_bb])\n",
    "\n",
    "# Display the DataFrame\n",
    "print(df_traing)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1324c1b6",
   "metadata": {},
   "source": [
    "## Compare models on GOLD dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "d79effef",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cpu\n",
      "Device set to use cpu\n",
      "Device set to use cpu\n",
      "Device set to use cpu\n"
     ]
    }
   ],
   "source": [
    "PROJECT_ROOT = os.path.expanduser('~/Documents/github/biomed_extractor')\n",
    "\n",
    "ner_pipeline_hf = pipeline(\n",
    "    \"token-classification\",\n",
    "    model=\"kamalkraj/BioELECTRA-PICO\",\n",
    "    aggregation_strategy=\"simple\"\n",
    ")\n",
    "\n",
    "model_dirs = [\n",
    "    os.path.join(PROJECT_ROOT, 'app/model/nlpie_compact_biobert_PICO'),\n",
    "    os.path.join(PROJECT_ROOT, 'app/model/nlpie_bio-mobilebert_PICO'),\n",
    "    os.path.join(PROJECT_ROOT, 'app/model/dmis-lab_biobert-v1.1')\n",
    "]\n",
    "\n",
    "ner_pipelines = [\n",
    "    load_ner_trained_pipeline(model_dir=dir_path)\n",
    "    for dir_path in model_dirs\n",
    "]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "df8f85ca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 195 records from study_details_supergoldseet.json\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "nctId",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "briefSummary",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "detailedDescription",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "inclusion_criteria",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "exclusion_criteria",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "intervention_name_clean",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "outcomes_name",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "ea04991a-b95e-4835-89f3-ea0d1702b53e",
       "rows": [
        [
         "0",
         "NCT02263885",
         "The proposed study will evaluate the safety, and initial efficacy of using the ExAblate Transcranial to create a unilateral lesion in the globus pallidus as an adjunct to PD medications in subjects who are over 30 years of age and considered medication-refractory with advanced idiopathic Parkinson's disease (PD).",
         "The purpose of this study is to evaluate the safety and initial clinical effectiveness of ExAblate Transcranial unilateral thermal ablation of the globus pallidus of subjects suffering from medication-refractory, advanced idiopathic PD.\n\nData will be collected to establish the basic safety and clinical efficacy of this type of treatment as the basis for later studies that will evaluate the full clinical efficacy.",
         "men and women, age 30 years and older; subjects who are able and willing to give informed consent and able to attend all study visits through 24 months; subjects with a diagnosis of idiopathic pd; levodopa responsive as defined by at least a 30% reduction in mds-updrs motor subscale in the on vs off medication state.; disabling motor complications of pd on optimum medical treatment; predominant disability from one side of the body (i.e unilateral or markedly asymmetric disease) as determined by movement disorders neurologist and neurosurgeon; subjects should be on a stable dose of all pd medications for 30 days prior to study entry.; subject is able to communicate sensations during the exablate transcranial procedure.",
         "presence of other central neurodegenerative disease suspected on neurological examination. these include: multisystem atrophy, progressive supranuclear palsy, corticobasal syndrome, dementia with lewy bodies, and alzheimer's disease.; any suspicion that parkinsonian symptoms are a side effect from neuroleptic medications.; subjects who have had deep brain stimulation or a prior stereotactic ablation of the basal ganglia; unstable psychiatric disease, defined as active uncontrolled depressive symptoms, psychosis, delusions, hallucinations, or suicidal ideation. subjects with stable, chronic anxiety or depressive disorders may be included provided their medications have been stable for at least 60 days prior to study entry and if deemed appropriately managed by the site neuropsychologist; subjects with significant depression as determined following a comprehensive assessment by a neuropsychologist.; legal incapacity or limited legal capacity as determined by the neuropsychologist; subjects exhibiting any behavior(s) consistent with ethanol or substance abuse; subjects with unstable cardiac status including: 1. unstable angina pectoris on medication 2. subjects with documented myocardial infarction within six months of protocol entry 3. significant congestive heart failure defined with ejection fraction \\ 100 on medication); current medical condition resulting in abnormal bleeding and/or coagulopathy; receiving anticoagulant (e.g. warfarin) or antiplatelet (e.g. aspirin) therapy within one week of focused ultrasound procedure or drugs known to increase risk or hemorrhage (e.g. avastin) within one month of focused ultrasound procedure; subjects with risk factors for intraoperative or postoperative bleeding as indicated by: platelet count less than 100,000 per cubic millimeter, a documented clinical coagulopathy, or inr coagulation studies exceeding the institution's laboratory standard; patient with severely impaired renal function with estimated glomerular filtration rate \\<30 ml/min/1.73m2 (or per local standards should that be more restrictive) and/or who is on dialysis;; subjects with standard contraindications for mr imaging such as non-mri compatible implanted metallic devices including cardiac pacemakers, size limitations, etc.; significant claustrophobia that cannot be managed with mild medication.; subjects who are not able or willing to tolerate the required prolonged stationary supine position during treatment.; history of intracranial hemorrhage; history of multiple strokes, or a stroke within past 6 months; subjects with a history of seizures within the past year; subjects with brain tumors; subjects with intracranial aneurysms requiring treatment or arterial venous malformations (avms) requiring treatment.; are participating or have participated in another clinical trial in the last 30 days; any illness that in the investigator's opinion preclude participation in this study.; subjects unable to communicate with the investigator and staff.; pregnancy or lactation.",
         "ExAblate Transcranial System",
         "Adverse Events"
        ],
        [
         "1",
         "NCT02337725",
         "The purpose of this study is to evaluate the efficacy and safety of TVP-1012 (1 mg/day) administered to Japanese patients with early Parkinson's disease.",
         "This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 study to evaluate the efficacy and safety of TVP-1012 in Japanese participants with early Parkinson's disease.\n\nThe study period consisted of a 28-week trial period. The participants who fulfill the inclusion criteria and not meeting any of the exclusion criteria were enrolled, and randomized in a 1:1 ratio to either the 1 mg of TVP-1012 or the placebo group. In each treatment group, participants received either 1 mg of TVP-1012 or placebo once daily in a double-blinded manner.",
         "run-in period; in the opinion of the investigator or sub-investigator, the participant is capable of understanding and complying with protocol requirements.; the participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.; the participant has a diagnosis of parkinson's disease with at least two of the following signs: resting tremor, akinesia/bradykinesia, and muscle rigidity.; the participant has a movement disorder society-unified parkinson's disease rating scale (mds-updrs) part ii + part iii total score of \\>=14 at the start of the run-in period.; the participant has modified hoehn \\& yahr stage 1 to 3 at the start of the run-in period.; the participant has the parkinson's disease diagnosed within 5 years prior to the start of the run-in period.; the participant is an outpatient of either sex aged \\>= 30 and \\= 14 at baseline.",
         "run-in period; the participant has received any investigational medication within 90 days prior to the start of the run-in period.; the participant has received tvp-1012 in the past.; the participant is study site employee, an immediate family member, or in a dependent relationship with a study site employee who is involved in the conduct of this study (e.g., spouse, parent, child, sibling) or may consent under duress.; participant has donated 400 ml or more of his or her blood volume within 90 days prior to the start of the run-in period.; the participant has unstable systemic disease.; the participant has mini-mental state examination (mmse) score of \\= 180 days.; the participant has received selegiline, a levodopa-containing product or dopamine agonist for \\>= 90 days.; the participant has received selegiline, pethidine, tramadol, reserpine or methyldopa within 90 days prior to the start of the run-in period.; the participant has received a levodopa-containing product, dopamine agonist, amantadine or anticholinergic drug within 30 days prior to the start of the run-in period.; the participant has received any psychoneurotic agent or antiemetic medication of dopamine antagonist within 14 days prior to the start of the run-in period. however, the participant has been receiving quetiapine or domperidone with a stable dose regimen for \\>= 14 days prior to the start of the run-in period may be included in the study.; the participant has previously received a catechol-o-methyltransferase (comt) inhibitor, droxidopa, zonisamide or istradefylline.; the participant is required to take any of the prohibited concomitant medications or treatments.; if female, the participant is pregnant or lactating or intending to become pregnant during this study, or within 1 month after the last dose of the investigational drug; or intending to donate ova during such time period.; the participant has clinically significant neurologic, cardiovascular, pulmonary, hepatic (including mild cirrhosis), renal, metabolic, gastrointestinal, urological, endocrine, or hematological disease.; the participant has clinically significant or unstable brain or cardiovascular disease, such as: ; clinically significant arrhythmia or cardiac valvulopathy, ; cardiac arrest of nyha class ii or higher, ; concurrent or a history of ischemic cardiac disease within 6 months prior to the start of the run-in period, ; concurrent or a history of clinically significant cerebrovascular disease within 6 months prior to the start of the run-in period, ; sever hypertension (systolic blood pressure of 180 mmhg or higher, or diastolic blood pressure of 110 mmhg or higher), ; clinically significant orthostatic hypotension (including those with systolic pressure decrease of 30 mmhg or more following postural change from supine/sitting position to standing position), ; a history of syncope due to hypotension within 2 years prior to the start of the run-in period.; the participant is required surgery or hospitalization for surgery during the study period; participant has a history of cancer within 5 years prior to the start of the run-in period, except cervix carcinoma in situ which has completely cured.; the participant has acquired immunodeficiency syndrome (aids) \\[including human immunodeficiency virus (hiv) carrier\\], or hepatitis \\[including viral hepatitis carrier such as hepatitis b surface (hbs) antigen or hepatitis c antibody (hcv) positive\\]. however, the participant who has a negative result for hcv antigen or hcv-rna can be included in the study.; the participant who, in the opinion of the investigator or sub-investigator, is unsuitable for any other reason.treatment period; the participant whose diagonosis of parkinson's disease is ruled out by dopamine transporter scintigraphy performed during the run-in period if conducted.; the participant has laboratory data meeting any of the following at the start of the run-in period: ; creatinine \\>= 2 x upper limit of normal (uln) ; total bilirubin \\>= 2 x uln ; alt or ast \\>= 1.5 x uln ; alp \\>= 3 x uln; the participant has received any of the prohibited concomitant medications or treatments during the run-in period.",
         "TVP-1012; Placebo",
         "Change From Baseline in Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II + Part III Total Score"
        ],
        [
         "2",
         "NCT02337738",
         "The purpose of this study is to evaluate the efficacy and safety of TVP-1012 (0.5 mg or 1 mg/day) as an add-on to levodopa in Japanese participants with Parkinson's disease with wearing-off phenomenon.",
         "This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, phase 2/3 study to evaluate the efficacy and safety of TVP-1012 as an add-on to levodopa in Japanese participants with Parkinson's disease with wearing-off phenomenon.\n\nThe study period consisted of a 28-week trial period. The participants who fulfilled the inclusion criteria and did not meeting any of the exclusion criteria were enrolled, and randomized in a 1:1:1 ratio to the 0.5 mg of TVP-1012, the 1 mg of TVP-1012, or the placebo group. In each treatment group, participants received 0.5 mg of TVP-1012, 1 mg of TVP-1012, or placebo once daily in a double-blinded manner.",
         "in the opinion of the investigator or sub-investigator, the participant is capable of understanding and complying with protocol requirements.; the participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.; the participant has a diagnosis of parkinson's disease according to the diagnostic criteria of the uk parkinson's disease society brain bank.; the participant has modified hoehn \\& yahr stage 2 to 4 (in the \"off\" state) at the start of the run-in period.; the participant has wearing off phenomenon and has been continuously receiving a levodopa combination drug for \\>= 6 months prior to the start of the run-in period.; the participant has been receiving a levodopa combination drug with a stable dose regimen (dosing frequency, at least 3 times a day) since the start of the run-in period.; for participants receiving eantacapone concomitantly,the participant has been receiving entacapone with a stable dose regimen from the start of the run-in period.; for participants receiving a dopamine agonist, anticholinergic drug, amantadine, droxidopa, istradefylline, or zonisamide concomitantly, the participant has been receiving those drugs with a stable dose regimen since 14 days prior to the start of the run-in period.; the participant is an outpatient of either sex aged \\>= 30 and \\= 2.5 hours at the end of the run-in period",
         "the participant has received any investigational medication within 90 days prior to the start of the run-in period.; the participant has received tvp-1012 in the past.; the participant is a study site employee, an immediate family member, or in a dependent relationship with a study site employee who is involved in the conduct of this study (e.g., spouse, parent, child, sibling) or may consent under duress.; participant has donated 400 ml or more of his or her blood volume within 90 days prior to the start of the run-in period.; the participant has unstable systemic disease.; the participant has severe dyskinesia.; the participant has mini-mental state examination (mmse) score of \\= 14 days prior to the start of the run-in period may be included in the study.; the participant is required to take any of the prohibited concomitant medications or treatments.; if female, the participant is pregnant or lactating or intending to become pregnant during, or within 1 month after the last administration of study medication in this study; or intending to donate ova during such time period.; the participant has clinically significant neurologic, cardiovascular, pulmonary, hepatic (including mild cirrhosis), renal, metabolic, gastrointestinal, urological, endocrine, or hematological disease.; the participant has clinically significant or unstable brain or cardiovascular disease, such as: ; clinically significant arrhythmia or cardiac valvulopathy, ; heart failure of nyha class ii or higher, ; concurrent or a history of ischemic cardiac disease within 6 months prior to the start of the run-in period, ; concurrent or a history of clinically significant cerebrovascular disease within 6 months prior to the stat of the run-in period, ; severe hypertension (systolic blood pressure of 180 mmhg or higher, or diastolic blood pressure of 110 mmhg or higher), ; clinically significant orthostatic hypotension (including those with diastolic pressure decrease of 30 mmhg or more following postural change from supine/sitting position to standing position), or ; a history of syncope due to hypotension within 2 years prior to the stat of the run-in period.; the participant is required surgery or hospitalization for surgery during the study period.; participant has a history of cancer within 5 years prior to the start of the run-in period, except cervix carcinoma in situ which has completely cured.; the participant has acquired immunodeficiency syndrome (aids) \\[including human immunodeficiency virus (hiv) carrier\\], or hepatitis \\[including viral hepatitis carrier such as hepatitis b surface (hbs) antigen or hepatitis c antibody (hcv) positive\\]. however, the participant who has a negative result for hcv antigen or hcv-rna can be included in the study.; the participant has laboratory data meeting any of the following at the start of the run-in period: ; creatinine \\>= 2 x upper limit of normal (uln) ; total bilirubin \\>= 2 x uln ; alt or ast \\>= 1.5 x uln ; alp \\>= 3 x uln; the participant has received any of the prohibited concomitant medications or treatments during the run-in period.; the participant who, in the opinion of the investigator or sub-investigator, is unsuitable for any other reason.",
         "TVP-1012; TVP-1012 0.; Placebo",
         "Change From Baseline in Mean Daily OFF-time During Treatment Period"
        ],
        [
         "3",
         "NCT02337751",
         "The purpose of this study is to evaluate the long-term safety of TVP-1012 (1 mg/day) in Japanese participants with early Parkinson's disease.",
         "This is a multicenter, open-label, long-term, extension, phase 3 study to evaluate the safety and efficacy of long-term administration of TVP-1012 at 1 mg for another 26 weeks in participants with early Parkinson's disease who have completed the preceding TVP-1012/CCT-001 (NCT02337725) study.\n\nAmong participants of the TVP-1012/CCT-001 study, those consenting to participate in this study prior to complete the preceding study and fulfilling the eligibility criteria will be enrolled in this study. From the day after the Visit 8 of the preceding study, participants will receive 1 mg of TVP-1012 once daily for 26 weeks in an unblinded manner.",
         "the participant has completed the preceding study.; the participant has shown no safety issues during the study treatment in the preceding study, in the opinion of the investigator or subinvestigator.",
         "the participant has undergone blood collection of \\>= 400 ml within 90 days prior to the start of treatment in this study.; the participant is required to take any of the excluded medications or treatments.; the participant is required surgery or hospitalization for surgery during the study period.",
         "TVP-1012",
         "Number of Participants Who Experience at Least One Treatment Emergent Adverse Event (TEAE)"
        ],
        [
         "4",
         "NCT02337764",
         "The purpose of this study is to evaluate long-term safety of TVP-1012 (1 mg/day) with levodopa in Japanese participants with Parkinson's disease.",
         "This is a multicenter, open-label, long-term, phase 3 study to evaluate the safety and efficacy of long-term administration of TVP-1012 at 1 mg with levodopa in Japanese participants with Parkinson's disease.\n\nThe study period consisted of a 2-week run-in period and a subsequent 52-week treatment period. Participants fulfilling the inclusion criteria and did not meet any of the exclusion criteria at the start of the run-in period (Week -2) and also at the end of the run-in period (Week 0) were enrolled in the study, and received 1 mg of TVP-1012 once daily for 52 weeks, in an unblinded manner, from the day after Week 0.",
         "in the opinion of the investigator or sub-investigator, the participant is capable of understanding and complying with protocol requirements.; the participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.; the participant has a diagnosis of parkinson's disease according to the diagnostic criteria of the uk parkinson's disease society brain bank.; the participant has received a levodopa combination drug for \\>= 1 month at the start of the run-in period and has either of the following. ; wearing off phenomenon ; decreased response to levodopa combination drugs; the participant has been receiving a levodopa combination drug a stable dose regimen since the start of the run-in period.; the participant is an outpatient of either sex aged \\>= 30 and \\= 14 days prior to the start of the run-in period may be included in the study.; the participant is required to take any of the prohibited concomitant medications or treatments.; if female, the participant is pregnant or lactating or intending to become pregnant during, or within 1 month after the last administration of study medication in this study; or intending to donate ova during such time period.; the participant has clinically significant neurologic, cardiovascular, pulmonary, hepatic (including mild cirrhosis), renal, metabolic, gastrointestinal, urological, endocrine, or hematological disease.; the participant has clinically significant or unstable brain or cardiovascular disease, such as: ; clinically significant arrhythmia or cardiac valvulopathy, ; heart failure of nyha class ii or higher, ; concurrent or a history of ischemic cardiac disease within 6 months prior to the start of the run-in period, ; concurrent or a history of clinically significant cerebrovascular disease within 6 months prior to the stat of the run-in period, ; severe hypertension (systolic blood pressure of 180 mmhg or higher, or diastolic blood pressure of 110 mmhg or higher), ; clinically significant orthostatic hypotension (including those with diastolic pressure decrease of 30 mmhg or more following postural change from supine/sitting position to standing position), or ; a history of syncope due to hypotension within 2 years prior to the stat of the run-in period.; the participant is required surgery or hospitalization for surgery during the study period.; participant has a history of cancer within 5 years prior to the start of the run-in period, except cervix carcinoma in situ which has completely cured.; the participant has acquired immunodeficiency syndrome (aids) \\[including human immunodeficiency virus (hiv) carrier\\], or hepatitis \\[including viral hepatitis carrier such as hepatitis b surface (hbs) antigen or hepatitis c antibody (hcv) positive\\]. however, the participant who has a negative result for hcv antigen or hcv-rna can be included in the study.; the participant with laboratory data meeting any of the following at the start of the run-in period: ; creatinine \\>= 2 x upper limit of normal (uln) ; total bilirubin \\>= 2 x uln ; alt or ast \\>= 1.5 x uln ; alp \\>= 3 x uln; the participant has received any of the prohibited concomitant medications or treatments during the run-in period; the participant who, in the opinion of the investigator or sub-investigator, is unsuitable for any other reason.",
         "",
         "TVP-1012",
         "Number of Participants Who Experience at Least One Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)"
        ]
       ],
       "shape": {
        "columns": 7,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nctId</th>\n",
       "      <th>briefSummary</th>\n",
       "      <th>detailedDescription</th>\n",
       "      <th>inclusion_criteria</th>\n",
       "      <th>exclusion_criteria</th>\n",
       "      <th>intervention_name_clean</th>\n",
       "      <th>outcomes_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02263885</td>\n",
       "      <td>The proposed study will evaluate the safety, a...</td>\n",
       "      <td>The purpose of this study is to evaluate the s...</td>\n",
       "      <td>men and women, age 30 years and older; subject...</td>\n",
       "      <td>presence of other central neurodegenerative di...</td>\n",
       "      <td>ExAblate Transcranial System</td>\n",
       "      <td>Adverse Events</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02337725</td>\n",
       "      <td>The purpose of this study is to evaluate the e...</td>\n",
       "      <td>This is a multicenter, randomized, double-blin...</td>\n",
       "      <td>run-in period; in the opinion of the investiga...</td>\n",
       "      <td>run-in period; the participant has received an...</td>\n",
       "      <td>TVP-1012; Placebo</td>\n",
       "      <td>Change From Baseline in Movement Disorder Soci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02337738</td>\n",
       "      <td>The purpose of this study is to evaluate the e...</td>\n",
       "      <td>This is a multicenter, randomized, double-blin...</td>\n",
       "      <td>in the opinion of the investigator or sub-inve...</td>\n",
       "      <td>the participant has received any investigation...</td>\n",
       "      <td>TVP-1012; TVP-1012 0.; Placebo</td>\n",
       "      <td>Change From Baseline in Mean Daily OFF-time Du...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02337751</td>\n",
       "      <td>The purpose of this study is to evaluate the l...</td>\n",
       "      <td>This is a multicenter, open-label, long-term, ...</td>\n",
       "      <td>the participant has completed the preceding st...</td>\n",
       "      <td>the participant has undergone blood collection...</td>\n",
       "      <td>TVP-1012</td>\n",
       "      <td>Number of Participants Who Experience at Least...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02337764</td>\n",
       "      <td>The purpose of this study is to evaluate long-...</td>\n",
       "      <td>This is a multicenter, open-label, long-term, ...</td>\n",
       "      <td>in the opinion of the investigator or sub-inve...</td>\n",
       "      <td></td>\n",
       "      <td>TVP-1012</td>\n",
       "      <td>Number of Participants Who Experience at Least...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         nctId                                       briefSummary  \\\n",
       "0  NCT02263885  The proposed study will evaluate the safety, a...   \n",
       "1  NCT02337725  The purpose of this study is to evaluate the e...   \n",
       "2  NCT02337738  The purpose of this study is to evaluate the e...   \n",
       "3  NCT02337751  The purpose of this study is to evaluate the l...   \n",
       "4  NCT02337764  The purpose of this study is to evaluate long-...   \n",
       "\n",
       "                                 detailedDescription  \\\n",
       "0  The purpose of this study is to evaluate the s...   \n",
       "1  This is a multicenter, randomized, double-blin...   \n",
       "2  This is a multicenter, randomized, double-blin...   \n",
       "3  This is a multicenter, open-label, long-term, ...   \n",
       "4  This is a multicenter, open-label, long-term, ...   \n",
       "\n",
       "                                  inclusion_criteria  \\\n",
       "0  men and women, age 30 years and older; subject...   \n",
       "1  run-in period; in the opinion of the investiga...   \n",
       "2  in the opinion of the investigator or sub-inve...   \n",
       "3  the participant has completed the preceding st...   \n",
       "4  in the opinion of the investigator or sub-inve...   \n",
       "\n",
       "                                  exclusion_criteria  \\\n",
       "0  presence of other central neurodegenerative di...   \n",
       "1  run-in period; the participant has received an...   \n",
       "2  the participant has received any investigation...   \n",
       "3  the participant has undergone blood collection...   \n",
       "4                                                      \n",
       "\n",
       "          intervention_name_clean  \\\n",
       "0    ExAblate Transcranial System   \n",
       "1               TVP-1012; Placebo   \n",
       "2  TVP-1012; TVP-1012 0.; Placebo   \n",
       "3                        TVP-1012   \n",
       "4                        TVP-1012   \n",
       "\n",
       "                                       outcomes_name  \n",
       "0                                     Adverse Events  \n",
       "1  Change From Baseline in Movement Disorder Soci...  \n",
       "2  Change From Baseline in Mean Daily OFF-time Du...  \n",
       "3  Number of Participants Who Experience at Least...  \n",
       "4  Number of Participants Who Experience at Least...  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load gold standard trials\n",
    "# Load and process data from clinicaltrials.gov\n",
    "PROJECT_ROOT = os.path.expanduser('~/Documents/github/biomed_extractor')\n",
    "\n",
    "# Data directory at top level\n",
    "DATA_DIR = os.path.join(PROJECT_ROOT, 'data\\\\annotated')\n",
    "\n",
    "df_json = load_trials_json(filepath = DATA_DIR, filename ='study_details_supergoldseet.json')\n",
    "#print(df_json.head())\n",
    "mydf_manual_annotation = extract_from_clinicaltrials(df_json)\n",
    "mydf_manual_annotation.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "33dd6f92",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n",
      "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BioELECTRA-PICO predictions:\n",
      "         nctId                                         population  \\\n",
      "0  NCT02263885  disabling motor complications of pd on optimum...   \n",
      "1  NCT02337725  iii total score of \\ > = 14 at the start of th...   \n",
      "2  NCT02337738  drug for \\ > = 6 months prior to the start of ...   \n",
      "3  NCT02337751                                                      \n",
      "4  NCT02337764  a history of syncope due to hypotension within...   \n",
      "\n",
      "                 intervention comparator              outcome  \\\n",
      "0       exablate transcranial                          safety   \n",
      "1                 of tvp 1012    placebo  efficacy and safety   \n",
      "2  1 mg of tvp 1012; levodopa    placebo  efficacy and safety   \n",
      "3                    tvp 1012                                   \n",
      "4          levodopa; tvp 1012                                   \n",
      "\n",
      "                                             summary  \n",
      "0  The proposed study will evaluate the safety, a...  \n",
      "1  The purpose of this study is to evaluate the e...  \n",
      "2  The purpose of this study is to evaluate the e...  \n",
      "3  This is a multicenter, open-label, long-term, ...  \n",
      "4  This is a multicenter, open-label, long-term, ...  \n",
      "nlpie_compact_biobert_PICO predictions:\n",
      "         nctId                                         population  \\\n",
      "0  NCT02263885  subjects suffering from medication - refractor...   \n",
      "1  NCT02337725  Japanese participants with early Parkinson ' s...   \n",
      "2  NCT02337738  Japanese participants with Parkinson ' s disea...   \n",
      "3  NCT02337751  Japanese participants with early Parkinson '; ...   \n",
      "4  NCT02337764  Japanese participants with Parkinson '; Japane...   \n",
      "\n",
      "                                        intervention comparator  \\\n",
      "0  allidus; exablate transcranial unilateral ther...              \n",
      "1                                   1 mg of tvp 1012    placebo   \n",
      "2  0 5 mg of tvp 1012; on; the 1 mg of tvp 1012; ...    placebo   \n",
      "3  1 mg of tvp 1012; cct; long term administratio...              \n",
      "4               1 mg of tvp 1012; long; term; vodopa              \n",
      "\n",
      "                                             outcome  \\\n",
      "0                                     adverse events   \n",
      "1  change from baseline in movement disorder soci...   \n",
      "2  change from baseline in mean daily off-time du...   \n",
      "3  number of participants who experience at least...   \n",
      "4  number of participants who experience at least...   \n",
      "\n",
      "                                             summary  \n",
      "0  The proposed study will evaluate the safety, a...  \n",
      "1  The purpose of this study is to evaluate the e...  \n",
      "2  The purpose of this study is to evaluate the e...  \n",
      "3  This is a multicenter, open-label, long-term, ...  \n",
      "4  This is a multicenter, open-label, long-term, ...  \n",
      "nlpie_bio-mobilebert_PICO predictions:\n",
      "         nctId                                         population  \\\n",
      "0  NCT02263885  globus pallidus; subjects suffering from medic...   \n",
      "1  NCT02337725  japanese participants with early parkinson ' s...   \n",
      "2  NCT02337738  japanese participants with parkinson ' s disea...   \n",
      "3  NCT02337751  2 / cct -; japanese participants with early pa...   \n",
      "4  NCT02337764   japanese participants with parkinson ' s disease   \n",
      "\n",
      "                                        intervention comparator  \\\n",
      "0  exablate transcranial unilateral thermal ablat...              \n",
      "1                                   1 mg of tvp 1012    placebo   \n",
      "2  0 5 mg of tvp 1012; levodopa; the 1 mg of tvp ...    placebo   \n",
      "3                             1 mg of tvp 1012; long              \n",
      "4                         1 mg of tvp 1012; levodopa              \n",
      "\n",
      "                                             outcome  \\\n",
      "0                                     adverse events   \n",
      "1  change from baseline in movement disorder soci...   \n",
      "2  change from baseline in mean daily off-time du...   \n",
      "3  number of participants who experience at least...   \n",
      "4  number of participants who experience at least...   \n",
      "\n",
      "                                             summary  \n",
      "0  The proposed study will evaluate the safety, a...  \n",
      "1  The purpose of this study is to evaluate the e...  \n",
      "2  The purpose of this study is to evaluate the e...  \n",
      "3  This is a multicenter, open-label, long-term, ...  \n",
      "4  This is a multicenter, open-label, long-term, ...  \n",
      "dmis-lab_biobert-v1.1 predictions:\n",
      "         nctId                                         population  \\\n",
      "0  NCT02263885  subjects suffering from medication - refractor...   \n",
      "1  NCT02337725  Japanese participants with early Parkinson ' s...   \n",
      "2  NCT02337738  Japanese participants with Parkinson ' s disea...   \n",
      "3  NCT02337751  Japanese participants with early Parkinson ' s...   \n",
      "4  NCT02337764   Japanese participants with Parkinson ' s disease   \n",
      "\n",
      "                                        intervention comparator  \\\n",
      "0  allidus; exablate transcranial unilateral ther...              \n",
      "1                                   1 mg of tvp 1012    placebo   \n",
      "2   0 5 mg of tvp 1012; the 1 mg of tvp 1012; vodopa    placebo   \n",
      "3  1 mg of tvp 1012; cct 001; long term administr...              \n",
      "4  1 mg of tvp 1012; long term administration of ...              \n",
      "\n",
      "                                             outcome  \\\n",
      "0                                     adverse events   \n",
      "1  change from baseline in movement disorder soci...   \n",
      "2  change from baseline in mean daily off-time du...   \n",
      "3  number of participants who experience at least...   \n",
      "4  number of participants who experience at least...   \n",
      "\n",
      "                                             summary  \n",
      "0  The proposed study will evaluate the safety, a...  \n",
      "1  The purpose of this study is to evaluate the e...  \n",
      "2  The purpose of this study is to evaluate the e...  \n",
      "3  This is a multicenter, open-label, long-term, ...  \n",
      "4  This is a multicenter, open-label, long-term, ...  \n"
     ]
    }
   ],
   "source": [
    "# Process all NER pipelines on the gold dataset and store results in a list\n",
    "ner_results = []\n",
    "\n",
    "# Process custom models\n",
    "for ner_pipeline in ner_pipelines:\n",
    "    ner_res_model = process_trials_for_retrained_PICO(mydf_manual_annotation, ner_pipeline)\n",
    "    ner_res_model.sort_values(by=['nctId'], inplace=True)\n",
    "    ner_res_model.rename(columns={\n",
    "        'population_extracted': 'population',\n",
    "        'intervention_extracted': 'intervention',\n",
    "        'comparator_extracted': 'comparator',\n",
    "        'outcome_extracted': 'outcome',\n",
    "        'summary_extracted': 'summary'\n",
    "    }, inplace=True)\n",
    "    # Only append, do not merge or concat\n",
    "    ner_results.append(ner_res_model[['nctId', 'population', 'intervention', 'comparator', 'outcome', 'summary']].copy())\n",
    "\n",
    "# Huggingface pipeline\n",
    "ner_res_model_hf = process_trials_for_PICO(mydf_manual_annotation, ner_pipeline_hf)\n",
    "ner_res_model_hf.sort_values(by=['nctId'], inplace=True)\n",
    "ner_res_model_hf.rename(columns={\n",
    "    'population_extracted': 'population',\n",
    "    'intervention_extracted': 'intervention',\n",
    "    'comparator_extracted': 'comparator',\n",
    "    'outcome_extracted': 'outcome',\n",
    "    'summary_extracted': 'summary'\n",
    "}, inplace=True)\n",
    "ner_results = [ner_res_model_hf[['nctId', 'population', 'intervention', 'comparator', 'outcome', 'summary']].copy()] + ner_results\n",
    "\n",
    "model_names = [\"BioELECTRA-PICO\", \"nlpie_compact_biobert_PICO\", \"nlpie_bio-mobilebert_PICO\", \"dmis-lab_biobert-v1.1\"]\n",
    "ner_results_dict = dict(zip(model_names, ner_results))\n",
    "\n",
    "# Peek into results\n",
    "for name, df in ner_results_dict.items():\n",
    "    print(f\"{name} predictions:\")\n",
    "    print(df.head())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "7f00dab6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 195 records from supergoldset_standard.json\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "doc_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "summary",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "intervention",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "comparator",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "outcome",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "population",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "ff2954b6-82f7-4df3-9ccb-4b7f2ee48cd4",
       "rows": [
        [
         "192",
         "NCT02263885",
         "[\"The proposed study will evaluate the safety, and initial efficacy of using the ExAblate Transcranial to create a unilateral lesion in the globus pallidus as an adjunct to PD medications in subjects who are over 30 years of age and considered medication-refractory with advanced idiopathic Parkinson's disease (PD).\"]",
         "exablate transcranial system",
         "-",
         "adverse events",
         "parkinson, 30 - 99"
        ],
        [
         "188",
         "NCT02337725",
         "[\"The purpose of this study is to evaluate the efficacy and safety of TVP-1012 (1 mg/day) administered to Japanese patients with early Parkinson's disease.\"]",
         "tvp 1012",
         "placebo",
         "change from baseline in movement disorder society-unified parkinson's disease rating scale (mds-updrs) part ii + part iii total score",
         "parkinson, 30 - 80"
        ],
        [
         "190",
         "NCT02337738",
         "[\"The purpose of this study is to evaluate the efficacy and safety of TVP-1012 (0.5 mg or 1 mg/day) as an add-on to levodopa in Japanese participants with Parkinson's disease with wearing-off phenomenon.\"]",
         "tvp 1012 1 mg 0 5 mg",
         "placebo",
         "change from baseline in mean daily off-time during treatment period",
         "parkinson, 30 - 79"
        ],
        [
         "191",
         "NCT02337751",
         "[\"The purpose of this study is to evaluate the long-term safety of TVP-1012 (1 mg/day) in Japanese participants with early Parkinson's disease.\"]",
         "tvp 1012",
         "placebo",
         "number of participants who experience at least one treatment emergent adverse event (teae)",
         "parkinson, 30 - 79"
        ],
        [
         "189",
         "NCT02337764",
         "[\"The purpose of this study is to evaluate long-term safety of TVP-1012 (1 mg/day) with levodopa in Japanese participants with Parkinson's disease.\"]",
         "tvp 1012",
         "-",
         "number of participants who experience at least one treatment emergent adverse events (teaes) and serious adverse events (saes)",
         "parkinson, 30 - 79"
        ],
        [
         "187",
         "NCT02349789",
         "[\"Gait and balance disturbances are one of the most incapacitating symptoms of Parkinson's disease (PD) (Boonstra et al. 2008). They can cause falls and are therefore associated with the negative spiral of (near) falls, fear of falling, fractures, reduced mobility and social isolation; hence, having a profound negative impact on quality of life (Lin et al. 2012). Originally, symptoms of PD were ascribed to dopamine deficiency and basal ganglia dysfunction (Wu et al. 2013). However, in the last decades it has become clear that other brain structures are also involved in the pathophysiology of PD (Snijders et al. 2011; Stefani et al. 2007). An intriguing, emerging insight is that the cerebellum may be involved in the pathophysiology of PD (Wu et al. 2013). That is, the cerebellum is hyperactive in PD patients during different motor tasks (Yu et al. 2007; Hanakawa et al. 1999; del Olmo et al. 2006). However, whether cerebellar hyperactivity is pathological or compensatory and how it affects gait and balance in PD patients remain open questions. Here, the investigators aim to elucidate the role of the hyperactive cerebellum in gait dysfunction in PD patients by modulating cerebellar excitability with state-of-the-art non-invasive brain stimulation techniques and investigate the effects on gait.\"]",
         "",
         "-",
         "-",
         "parkinson, 18 - 99"
        ],
        [
         "193",
         "NCT02352363",
         "[\"This study is a 12-month, open-label, randomized, multicenter study which will evaluate the safety and efficacy of CVT-301 for the treatment of up to 5 OFF episodes per day in Parkinson's Disease (PD) patients experiencing motor fluctuations (OFF episodes) and will include a concurrent observational cohort of PD patients managed using the usual standards of care.\"]",
         "cvt 301",
         "-",
         "pulmonary safety of cvt-301 change from baseline for fev1, pulmonary safety for cvt-301 change from baseline for fvc, pulmonary safety for cvt-301 change from baseline for (fev1/fvc)",
         "parkinson, 30 - 86"
        ],
        [
         "186",
         "NCT02352363",
         "[\"This study is a 12-month, open-label, randomized, multicenter study which will evaluate the safety and efficacy of CVT-301 for the treatment of up to 5 OFF episodes per day in Parkinson's Disease (PD) patients experiencing motor fluctuations (OFF episodes) and will include a concurrent observational cohort of PD patients managed using the usual standards of care.\"]",
         "cvt 301",
         "standard of care",
         "pulmonary safety assessed by forced expiratory volume in 1 second [fev1], pulmonary safety assessed by forced vital capacity [fvc], pulmonary safety assessed by forced expiratory volume in 1 second / forced vital capacity ratio",
         "parkinson, 30 - 85"
        ],
        [
         "185",
         "NCT02358876",
         "['Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with motion sensor measures, determine if speed, amplitude, and rhythm fluctuate differentially throughout the day in individuals with implanted deep brain stimulation systems, receive feedback on the usability of Kinesia One, and evaluate Kinesia One compliance in the home.']",
         "kinesia one assessments",
         "-",
         "percentage of kinesia one assessments performed",
         "parkinson, 18 - 99"
        ],
        [
         "184",
         "NCT02365870",
         "[\"This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.\"]",
         "rotigotine transdermal patch",
         "placebo",
         "change in anxiety symptom severity as assessed by the hamilton anxiety rating scale",
         "parkinson, 21 - 89"
        ],
        [
         "183",
         "NCT02380859",
         "[\"Subjects diagnosed with Idiopathic Parkinson's Disease, between ages of 40-85 inclusive, who have been referred for gait training. Since there can be subtle differences in the brain organization of left- and right-handed people that may influence some of the measurements, right handed participants are preferred. However, a left handed participant may be considered. Participants will be randomly assigned to one of two groups to undergo two weeks of twice-daily sessions. Group A receiving goggles fitted with lenses that distort vision and Group B patients receiving sham goggles\"]",
         "prism adaptation",
         "neutral lenses",
         "change in postural control - reaction time on the limits of stability test (smart equitest balance master system), change in postural control - maximum velocity on the limits of stability test (smart equitest balance master system), change in postural control - maximum extension on the limits of stability test (smart equitest balance master system), change in postural control - composite score on the sensory organization test smart equitest balance master, change in postural control - forward-backward displacement of centre of gravity on the sensory organization test smart equitest balance master, change in postural control - composite latency score on the motor control test, change in postural control - composite latency score on the berg balance scale",
         "parkinson, 40 - 85"
        ],
        [
         "182",
         "NCT02384421",
         "['Continuous deep brain stimulation (cDBS) is an established therapy for the major motor signs in Parkinson\\'s disease. Currently, cDBS is limited to \"open-loop\" stimulation, without real-time adjustment to the patient\\'s state of activity, fluctuations and types of motor symptoms, medication dosages, or neural markers of the disease. The purpose of this study is to determine if an adaptive DBS system, responding to patient specific, clinically relevant neural or kinematic feedback, is efficacious on the motor Unified Parkinson\\'s Disease Rating Scale (UPDRS III) and specific phenotypic measures in Parkinson\\'s Disease compared to OFF therapy (i.e., OFF DBS and withdrawn from medication) and more efficient than cDBS. Not every recruited participant completed every part of the protocol.']",
         "deep brain stimulation adaptive dbs",
         "-",
         "normalized beta band power (13-30 hz) during adbs, change in updrs iii score",
         "parkinson, 18 - 80"
        ],
        [
         "181",
         "NCT02401308",
         "['The purpose of the proposed study is to demonstrate that the functional outcomes of DBS surgery utilizing the \"asleep\" technique are not inferior to those reported for traditional \"awake\" DBS technique.']",
         "deep brain stimulation awake surgery",
         "asleep deep brain stimulation surgery",
         "functional outcomes",
         "parkinson, 18 - 85"
        ],
        [
         "180",
         "NCT02418546",
         "[\"This is a phase II feasibility, safety, tolerability and preliminary efficacy study of an e-Health application versus in-person nutritional counseling to maintain or increase weight in patients with neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's Disease (PD) and Huntington's disease (HD). Primary Objectives include the feasibility, safety, tolerability and efficacy of an e-Health application to maintain or increase body weight compared to in-person nutritional counseling. Secondary Objectives are to measure the number of calories required to maintain or increase body weight in neurodegenerative diseases at all stages of the disease. Tertiary Objectives are to test the effects of an e-Health application compared to in-person nutritional counseling on disease progression using the ALSFRS-R, UHDRS or UDysRS, on survival, and on quality of life using the PROMIS SF v1.1 scale.\"]",
         "nutritional counseling using an e health application",
         "in-person nutritional counseling",
         "estimated mean change in weight from baseline to 6 months",
         "parkinson, 18 - 99"
        ],
        [
         "179",
         "NCT02448914",
         "[\"This study evaluates the continuous addition of entacapone to infused levodopa and carbidopa on the pharmacokinetic (PK) profile in patients with advanced Parkinson's disease (PD). All patients will receive both study drugs, i.e. TRIGEL (levodopa, carbidopa, and entacapone) and Duodopa (levodopa and carbidopa), in randomized order.\"]",
         "trigel then duodopa",
         "duodopa, then trigel",
         "dose adjusted area under the curve (auc) (0-14h) for levodopa",
         "parkinson, 30 - 99"
        ],
        [
         "178",
         "NCT02453386",
         "['Phase 3, international, multicenter, randomized, double-blind, placebo-controlled, parallel-group, 3-arm safety and efficacy study (Part A) with an open-label phase (Part B).']",
         "tozadenant 60mg 120mg",
         "placebo",
         "change from baseline to week 24 in the number of hours per day spent in off time",
         "parkinson, 30 - 80"
        ],
        [
         "177",
         "NCT02462603",
         "['Open-label study with 30-day run-in phase and adaptive design component to include more participants if deemed appropriate by investigators.']",
         "ptc 589",
         "-",
         "number of participants with drug-related serious adverse events (saes)",
         "parkinson, 21 - 75"
        ],
        [
         "176",
         "NCT02469090",
         "['A 12-week, prospective, multi-center, randomized, double-blind, placebo controlled, Phase 3 study in L-Dopa responsive PD patients with motor fluctuations (\"OFF\" episodes), designed to determine the efficacy, safety and tolerability of APL-130277.']",
         "apl 130277",
         "placebo",
         "mean change from pre-dose to 30 minutes post-dose in the movement disorders society unified parkinson's disease rating scale part iii motor examination (mds-updrs part iii) score at maintenance visit 4 (mv4) - week 12",
         "parkinson, 18 - 99"
        ],
        [
         "175",
         "NCT02470780",
         "[\"This study investigates the effect of treating Small Intestinal Bacterial Overgrowth (SIBO) in patients with Parkinson's Disease (PD). It will test the hypothesis that treating SIBO with the antibiotic rifaximin will improve motor complications in previously SIBO-positive PD patients.\"]",
         "rifaximin",
         "placebo",
         "change in \"off\" time as measured by patient diary, change in \"off\" time as measured by wireless computer monitoring system",
         "parkinson, 18 - 99"
        ],
        [
         "174",
         "NCT02474329",
         "[\"Background: Long-term management of Parkinson's disease (PD) does not reach its full potential due to lack of knowledge about disease progression. The Real-PD study aim to evaluate the feasibility and compliance of usage of wearable sensors in PD patients in real life. Moreover, an explorative analysis concerning activity level, medication intake and mood will be done.\\n\\nMethods: Overall, 1000 PD patients and 250 physiotherapist will be enrolled in this observational study. Dutch PD patients will be recruited across the country and an assessment will be performed using a short version of the Parkinson's Progression Markers Initiative (PPMI) protocol. Moreover, participants will wear a set of medical devices (Pebble Smartwatch, fall detector) and they will use a smartphone with The Fox Insight App (Android app), 24/7, during 13 weeks. Primary measures of interest are: 1) physical activity, falls and tremor, measured by the axial accelerometers embedded in the Pebble watch and fall detector; and 2) medication intake and mood reports measured by patients' self-report in the Android app. To measure motor impact, an assessment will be performed by physiotherapists who are all certified to perform the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS).\\n\\nDiscussion: Management of PD patients is complex and appears to be a challenging task for health care professionals. The main reason is the lack of knowledge in the disease pattern. This issue could be solved by a long term follow-up of patients' during their everyday life, and wearable medical devices can act as a way to collect data about every day life activities. Therefore, the Real-PD study will be a first contribution in increasing the lack of knowledge in disease progression, developing a new medical decision system and improving PD patients' care.\"]",
         "fox insight self monitoring android app",
         "-",
         "parkinson's disease symptoms",
         "parkinson, 30 - 99"
        ],
        [
         "173",
         "NCT02475954",
         "[\"When Veterans with Parkinson's disease (PD) suffer from depression, they are more likely to experience disease complications, interpersonal difficulties with caregivers, and poorer quality of life. Unfortunately, depression in Veterans with PD is inadequately treated at the current time. Treatment for depressed Veterans with PD will require the elimination of geographical barriers to care and approaches that address the unique aspects of PD. The proposed study will be the first to explore a novel and innovative, PD-informed psychotherapy package for depressed Veterans with PD and their Caregivers, delivered through video-to-home telehealth. If the results of this proposal are promising, a much needed treatment can be made available to Veterans with PD and their Caregivers across the country, regardless of geographical location.\"]",
         "th cbt",
         "standard of care",
         "hamilton depression rating scale",
         "parkinson, 35 - 85"
        ],
        [
         "172",
         "NCT02533921",
         "[\"The purpose of this study is to improve outcomes for persons living with Parkinson's Disease (PD) and their family caregivers. The investigators hypothesize that outpatient interdisciplinary palliative care will improve patient-centered outcomes for PD patients at high-risk for poor outcomes.\"]",
         "interdisciplinary outpatient palliative care",
         "standard of care",
         "changes in the subjects quality of life (qol), changes in caregiver distress",
         "parkinson, 40 - 99"
        ],
        [
         "171",
         "NCT02538029",
         "[\"The primary aim of the proposed project is to characterize dual tasking (DT) deficits to improve motor, cognitive, and quality of life outcomes in individuals with Parkinson's disease (PD). Phase 1 of the intervention will involve an in-depth gait analysis on 15 individuals with PD. This gait analysis will utilize the Computer Assisted Rehabilitation Environment (CAREN) system, a virtual reality system with a fully integrated 3-D motion capture system. The purpose of Phase 1 is to generalize characteristics of gait and postural control during specific DT conditions. Phase 2 (N=20) involves the clinical translation of these findings. This phase will involve creating a clinical intervention based on the objective information gathered the CAREN system. The intervention will take place 3x/week for a total of 8 weeks. Interventional groups will include: 1) DT clinical group (N=10) and 2) Single task group (N=10). Outcome measures will be used at the beginning and end of the intervention to assess the feasibility and efficacy of the intervention.\"]",
         "dual task group",
         "single task group",
         "step length during gait, walking speed during gait",
         "parkinson, 00 - 99"
        ],
        [
         "170",
         "NCT02542696",
         "['An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of \"OFF\" Episodes in Patients With Parkinson\\'s Disease']",
         "apl 130277",
         "-",
         "evaluation of safety and tolerability data collected, based on number of participants with adverse events in the lts phase",
         "parkinson, 18 - 99"
        ],
        [
         "168",
         "NCT02549092",
         "['The primary objective of this study is to examine the effect of LCIG relative to that of OMT on NMS associated with PD.']",
         "levodopa carbidopa intestinal gel",
         "optimized medical treatment (omt)",
         "change from baseline to week 26 in the nmss total score, change from baseline to week 26 in the modified pdss-2 total score",
         "parkinson, 30 - 99"
        ],
        [
         "167",
         "NCT02549573",
         "['To determine if PT intervention will be improved while in the \"on\" motor state vs. the \"end-of-dose-off\" motor state during the PT Intervention Visit in subjects with PD.']",
         "apokyn treatment withheld before physical therapy",
         "apokyn treatment before physical therapy",
         "change from baseline in activities-specific balance confidence (abc) scale",
         "parkinson, 18 - 78"
        ],
        [
         "169",
         "NCT02549859",
         "['Our recent study (Xie et al, Neurology 2015; 84: 415-420) found that bilateral STN DBS of 60Hz, compared to the traditional 130Hz, decreased the aspiration frequency and swallowing difficulty, freezing of gait (FOG), and other axial symptoms and parkinsonism in Parkinson patients with FOG refractory to 130Hz and medications. The benefit of 60Hz stimulation persisted during the 6-week study period, but with worsening tremor in one patient. However, it remains unknown whether the benefit of 60Hz would persist on prolonged stimulation period, and whether there is carry-over effect across different conditions. Hence, the investigators would like to test the hypothesis that the 60Hz stimulation, compared to 130Hz might have persistent benefit over an extended period in reducing the swallowing dysfunction, FOG, and other axial symptoms in these PD patients even after correcting the potential carry-over effect.']",
         "deep brain stimulation at 60 hz 130 hz",
         "deep brain stimulation (dbs) off (sham)",
         "frequency of aspiration events on videofluoroscopic swallow study at visit 1&2, perceived swallowing difficulty on swallowing disturbance questionnaire at visit 1&2, freezing of gait questionnaire at visit 1&2, stand-walk-sit freezing of gait spells at visit 1&2, stand-walk-sit time at visit 1&2",
         "parkinson, 45 - 75"
        ],
        [
         "166",
         "NCT02565628",
         "[\"This study is designed to assess safety, tolerability and pharmacokinetic data for multiple doses of PF-06669571 in subjects with idiopathic Parkinson's disease. In addition, this study will assess whether PF-06669571 is able to demonstrate superior efficacy compared with placebo in the treatment of the motor symptoms of idiopathic Parkinson's disease.\"]",
         "pf 06669571",
         "placebo",
         "maximum percent change from baseline in movement disorder society-sponsor revision of the unified parkinson's disease rating scale (mds-updrs) part iii at day 7, number of participants in each columbia classification algorithm of suicide assessment (c-casa) category by study visit on day -2, day 8 or early withdrawal, and early withdrawal/follow-up visit, number of participants with new onset and worsening of post-baseline suicidality, number of participants with treatment emergent adverse events (all causalities), number of participants with supine and standing vital sign abnormalities of potential clinical concern (absolute values), number of participants with supine and standing vital sign abnormalities of potential clinical concern (increase from baseline), number of participants with supine and standing vital sign abnormalities (decrease from baseline), number of participants with electrocardiogram (ecg) that met categorical criteria for concern (absolute value), primary: number of participants with electrocardiogram (ecg) that met categorical criteria for concern(increase from baseline), number of participants with laboratory abnormalities that met categorical criteria for concern (without regard to baseline abnormality)",
         "parkinson, 45 - 85"
        ],
        [
         "165",
         "NCT02577523",
         "['This is a multicenter, parallel-group, rater-blinded, randomized clinical study in subjects with advanced PD investigating the efficacy, PK, safety and tolerability of continuous SC infusion of 2 dosing regimens of ND0612H, a solution of LD/CD delivered via a pump system as a continuous SC infusion, compared to standard oral LD/CD. After screening, subjects will undergo 1 day of standard oral LD/CD inpatient dosing followed by 2 days of inpatient treatment with 1 of 2 randomly allocated (1:1 randomization ratio) dosing regimens of ND0612H continuous SC infusion. Subjects will then continue on a maintenance dose of the assigned ND0612H dosing regimen for the next 25 days. A safety visit will be performed 4 weeks after the last SC administration of the study drug for a total of about 2.5 months of participation for each subject enrolled into the trial.']",
         "nd0612",
         "-",
         "change in daily \"off\" time",
         "parkinson, 30 - 80"
        ],
        [
         "164",
         "NCT02586623",
         "[\"To evaluate the time to treatment intervention in patients with Parkinson's Disease (PD), Multiple System Atrophy (MSA), Pure Autonomic Failure (PAF), Non-Diabetic Autonomic Neuropathy (NDAN) or Dopamine Beta Hydroxylase (DBH) Deficiency who have been previously stabilized with droxidopa therapy for symptoms of neurogenic orthostatic hypotension (NOH) (dizziness, light-headedness, or feelings that they are about to black out)\"]",
         "droxidopa capsules",
         "placebo",
         "time to intervention",
         "symptomatic orthostatic hypotension associated with primary autonomic failure (pd, msa or paf) or ndan or dbh deficiency, 18 - 99"
        ],
        [
         "163",
         "NCT02598973",
         "['Parkinson\\'s disease (PD) is a common neurodegenerative disorder affecting approximately 80,000 Veterans, representing a priority area for VA research. Current medicines for PD only improve symptoms, treatments that slow disease progression are needed, and earlier diagnosis of PD may be the key to their development. PD symptoms can be mimicked by medicines (most commonly antipsychotic drugs that block dopamine), and some of these patients actually have underlying \"prodromal\" PD that was \"unmasked\" years before it would have caused symptoms. This problem is increasing as these medicines are now used for common conditions including post-traumatic stress disorder and depression. The investigators will identify prodromal PD in patients with drug-induced symptoms using brain scans. These patients will be enrolled in a randomized clinical trial of aerobic exercise which slows progression in animal models of PD and has other health benefits. The investigators will measure the effect of exercise on symptoms, disease progression (using brain scans) and markers of PD risk (using blood tests). These studies will improve early PD diagnosis and potentially identify a way to slow progression of PD.']",
         "exercise aerobic walking",
         "no intervention",
         "change in dopamine transporter imaging",
         "parkinson, 45 - 89"
        ],
        [
         "162",
         "NCT02610231",
         "[\"This is a Phase 3, 52-week, open-label, flexible-dose, multinational, multicenter study to evaluate the safety and tolerability of istradefylline 20 or 40 mg/d in subjects with moderate to severe PD with motor fluctuations and dyskinesia on levodopa combination (levodopa/carbidopa or levodopa/benserazide) therapy plus at least one adjunctive PD medication. Subjects who completed 12 weeks of double-blind treatment and the 30-day follow-up period in Study No. 6002-014 will undergo Screening and Baseline evaluations for eligibility for the study. Eligible subjects will be treated with istradefylline at a starting dose of 20 mg/d with an option for a dose adjustment to 40 mg/d at Week 12 based on the Investigator's judgment of each subject's response and tolerability. If deemed necessary, one unscheduled dose adjustment visit between Week 2 to Week 12 is allowed in accordance with clinical judgment of the Investigator. Subjects who had a dose adjustment to 40 mg/d can have their dose decreased to 20 mg/d by the Investigator at a second unscheduled dose adjustment visit if there are tolerability issues. The istradefylline dose should remain fixed between Week 26 to Week 52. Consultation with the Sponsor's Medical Monitor is required prior to any unscheduled dose adjustment visits. A subject may discontinue from the study at any time.\"]",
         "istradefylline 20 mg",
         "-",
         "evaluation of the long-term safety and tolerability of oral istradefylline (20mg or 40mg/day [mg/d])",
         "parkinson, 30 - 99"
        ],
        [
         "161",
         "NCT02642393",
         "[\"A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial to determine whether oral inosine dosed to moderately elevate serum urate (from 5.7 mg/dL to 7.1-8.0 mg/dL) over 2 years slows clinical decline in early PD.\\n\\nClinical decline will be assessed as change in the primary outcome variable of the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), a composite scale comprising patient- and clinician-reported outcomes.\"]",
         "inosine",
         "placebo",
         "rate of clinical decline",
         "parkinson, 30 - 99"
        ],
        [
         "160",
         "NCT02649608",
         "[\"To evaluate the safety, tolerability, pharmacokinetics, and efficacy of the Lu AE04621 and metabolite after ascending oral doses of Lu AE04621 in patients with Parkinson's Disease.\"]",
         "lu ae04621",
         "-",
         "safety and tolerability based on the safety variables (adverse events, clinical safety laboratory tests, vital signs, weight, and ecg)",
         "parkinson, 40 - 75"
        ],
        [
         "159",
         "NCT02687542",
         "[\"The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients who experience motor-fluctuations.\"]",
         "pf 06649751",
         "placebo",
         "change from baseline in daily off time at week 10",
         "parkinson, 40 - 85"
        ],
        [
         "158",
         "NCT02701647",
         "[\"The purpose of this study is to investigate whether the beneficial effect of treadmill training on people with Parkinson's disease can be enhanced by high- and low-frequency repetitive transcranial magnetic stimulation (rTMS).\"]",
         "repetitive transcranial magnetic stimulation",
         "sham-tt",
         "fastest walking speed",
         "parkinson, 40 - 70"
        ],
        [
         "157",
         "NCT02702102",
         "[\"This study uses a special type of scan called a positron emission tomography (PET) scan to take pictures of the brain. During the PET scan, a special dye called 11C-PBR28 is injected into the body.\\n\\n11C-PBR28 sticks to parts of the brain where there is inflammation. The purpose of this study is to see if 11C-PBR28 can detect inflammation in patients with Parkinson's disease dementia or dementia with Lewy bodies.\\n\\n11C-PBR28 is considered a drug by the Food and Drug Administration. 11C-PBR28 is not a treatment for any disease. Rather, 11C-PBR28 can be used to measure inflammation in the brain.\"]",
         "11c pbr28",
         "-",
         "absolute 11c-pbr28 binding (total distribution volume corrected for free fraction in plasma)",
         "parkinson and dementia, 60 - 99"
        ],
        [
         "156",
         "NCT02703844",
         "[\"The purpose of this study is to determine whether caloric vestibular stimulation improves symptoms of Parkinson's Disease.\"]",
         "caloric vestibular stimulation",
         "placebo",
         "change from baseline in the nonmotor symptom severity scale (nmss)",
         "parkinson, 18 - 95"
        ],
        [
         "155",
         "NCT02705586",
         "['To evaluate the feasibility of a video based mindfulness intervention for stress reduction and to evaluate the cortisol response in persons with PD and their caregivers. The data from this project will be used for a future grant application of a stress reduction intervention in persons with PD.']",
         "mindfulness",
         "-",
         "salivary cortisol levels (pre- and post-) mindfulness-based stress reduction program",
         "parkinson, 18 - 99"
        ],
        [
         "154",
         "NCT02708186",
         "[\"This study seeks to evaluate the safety and efficacy of Nelotanserin for the treatment of Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with dementia with Lewy bodies (DLB) or Parkinson's disease dementia (PDD).\"]",
         "nelotanserin",
         "placebo",
         "change in the frequency of rem sleep behavior disorders (rbd) from baseline to the end of the treatment period (28 days) based on a clinical evaluator",
         "parkinson and dementia, 50 - 99"
        ],
        [
         "153",
         "NCT02726386",
         "[\"This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a continuous SC infusion in subjects with advanced Parkinson's Disease (PD).\"]",
         "nd0612",
         "-",
         "adverse events (long-term safety), percentages of subjects who complete the 12-month treatment period or discontinue due to ae (tolerability)",
         "parkinson, 30 - 99"
        ],
        [
         "152",
         "NCT02727478",
         "[\"This effectiveness-implementation study is a part of the larger study BETA-PD (Balance, Elderly, Training and Activity in Parkinson's Disease), which has the long-term goal to reduce the risk of falling in people with Parkinson's disease (PD) by improving balance, gait and physical activity level. The main hypothesis is that highly challenging balance training will lead to greater gait and balance ability, increased levels of physical activity and an improved health related quality of life. The main aims of the study are to evaluate the effectiveness of the HiBalance program in real-life clinical settings, while exploring facilitators and barriers for program implementation on a wider scale.\"]",
         "hibalance training program",
         "no intervention",
         "change in mini-bestest score from baseline at 1 week post intervention",
         "parkinson, 18 - 99"
        ],
        [
         "151",
         "NCT02728843",
         "[\"The goal of this study is to evaluate the effects of deferiprone, an iron-chelating drug, in patients with Parkinson's disease. Participants will be randomized to receive one of four different dosages of deferiprone or placebo, and will take the assigned study product twice a day for nine months.\"]",
         "deferiprone 300 mg 600 mg 900 mg 1200 mg",
         "placebo",
         "change in score on the part iii subscale of the movement disorder society-unified parkinson's disease rating scale (mds-updrs)",
         "parkinson, 18 - 80"
        ],
        [
         "150",
         "NCT02789020",
         "[\"Parkinson's disease (PD) is a neurodegenerative brain disorder that impairs the ability to perform functions such as grooming, dressing, cooking, and other activities of daily living. PD affected between 4.1 and 4.6 million people worldwide in 2005, and it is projected that up to 9.3 million people will be affected by 2030. Although current pharmacological therapies provide beneficial effects on motor symptoms of the disease (tremor, rigidity, and bradykinesia), intolerable disability eventually develops in most patients. A disease-modifying therapy that slows disease progression is a major unmet medical need in PD. Numerous agents have neuroprotective effects in pre-clinical laboratory models, but none have been shown to have indisputable disease-modifying effects in clinical trials for patients with PD.\\n\\nThe purpose of this research study is to investigate how the brain and motor behavior changes in PD over time in response to rasagiline which is a monoamine oxidase-B(MAO-B) inhibitor. The drug rasagiline will be tested in this study as the MAO-B inhibitor. Rasagiline has been prescribed for many years to treat symptomatic Parkinson's disease. It is FDA approved for the treatment of Parkinson's disease but has not been shown to slow disease progression. The outcome and impact of this study will provide the first evaluation of MAO-B inhibitors at slowing the progression of the nigrostriatal pathway using advanced Magnetic Resonance Imaging (MRI) and functional Magnetic Resonance Imaging (fMRI) methods in PD.\"]",
         "rasagiline magnetic resonance imaging",
         "placebo",
         "change in free-water accumulation in the substantia nigra, change in blood oxygen level-dependent(bold) signal in the posterior putamen, m1, and supplementary motor area(sma)",
         "parkinson, 40 - 77"
        ],
        [
         "149",
         "NCT02799381",
         "[\"The primary objective of this study was to examine the effect of levodopa-carbidopa intestinal gel (LCIG) compared with optimized medical treatment (OMT) on dyskinesia in participants with advanced Parkinson's disease (PD).\"]",
         "levodopa carbidopa intestinal gel",
         "optimized medical treatment (omt)",
         "mean change from baseline to week 12 in unified dyskinesia rating scale (udysrs) total score",
         "parkinson, 30 - 99"
        ],
        [
         "148",
         "NCT02803749",
         "[\"Anxiety is highly prevalent in Parkinson's disease and negatively impacts quality of life yet it frequently remains untreated and there have been no clinical trials dedicated to evaluating the pharmacological treatment of anxiety in Parkinson's disease. Buspirone is effective for the treatment of generalized anxiety disorder in the general and elderly population. It is not known if it is effective for the treatment of anxiety in Parkinson's disease. This is a single-center, placebo-controlled, double-blind design with participants randomized with a 4:1 allocation ratio to flexible dosage buspirone (maximum dosage 30 mg twice daily) or placebo for 12 weeks.\"]",
         "buspirone",
         "placebo",
         "the number of participants who fail to complete the 12-week study on study drug.",
         "parkinson, 18 - 99"
        ],
        [
         "146",
         "NCT02818777",
         "['The major purpose of the Stage 1 is to study the safety and tolerability of the proposed dosage regimen of the study drug. The form of cannabidiol (CBD) used in this study is GWP42003, supplied by GW Pharmaceuticals. The dosage regime is based on their experience. This is an open label study in 10 subjects, during which the dose is gradually increased to the manufacturers recommended target dose, with tolerability being evaluated at each dose level. Based on the response of subjects in the Stage 1, a target dose is determined for the next stage. Standardized tools will be administered to study both tolerability and efficacy. Efficacy assessments are simply explorative, and are done to look for an effect that warrants specific or different evaluation in the next stage.']",
         "cannabidiol",
         "-",
         "severity of participants reporting study-related adverse events at each dose level, number of participants had changes in orthostatic blood pressure, number of participants had changes in physical exam, number of participants had changes in ekg, number of participants had changes in laboratory values, proportion of subjects that drop out of the study due to study drug intolerance, change in movement disorder society-unified parkinsons disease rating scale total score, change in montreal cognitive assessment (moca), change in anxiety short form, change in neuropsychiatric inventory (npi), change in depression short form, change in scales for outcomes in parkinson's disease (scopa)-sleep-night time sleep, change from baseline of rem sleep behavior disorder screening questionnaire (rbdsq), change in emotional and behavioral dyscontrol short form, change in pain severity form, change in questionnaire for impulsive-compulsive disorders in parkinson's disease-rating scale (quip-rs), change in fatigue severity scale, change in international restless legs syndrome study group rating scale for restless, change in unified dyskinesia rating scale (udysrs)",
         "parkinson, 40 - 80"
        ],
        [
         "147",
         "NCT02819011",
         "['The investigators propose a randomized control trial to evaluate long term effects and effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of falling in older adults.\\n\\nPrimary Endpoints  Characterize the impact of MBB AFO on balance, gait, risk of falling, frailty status, and adverse events\\n\\nSecondary Endpoints  Characterize the Impact of MBB AFO on spontaneous daily physical activities  Characterize the feasibility of the MBB AFO device on patient adherence, acceptability, user-friendliness, and perception of benefit for daily usage']",
         "mbb afo",
         "no mbb afo",
         "hip sway change from baseline to 6 months, ankle sway change from baseline to 6 months, center of mass (com) sway change baseline to 6 months",
         "people with high risk of fall, 65 - 99"
        ],
        [
         "145",
         "NCT02847650",
         "[\"The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.\"]",
         "pf 06649751",
         "placebo",
         "change from baseline in the movement disorder society - unified parkinson's disease rating scale (mds-updrs) part iii total score at week 15",
         "parkinson, 45 - 80"
        ],
        [
         "144",
         "NCT02898740",
         "[\"This project is investigating whether a home-based exercise program will reduce depression in patients with Parkinson's disease.\"]",
         "structural exercise",
         "health education",
         "change in hamilton rating scale for depression (ham-d) from baseline to 6 months",
         "parkinson, 40 - 99"
        ]
       ],
       "shape": {
        "columns": 6,
        "rows": 195
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doc_id</th>\n",
       "      <th>summary</th>\n",
       "      <th>intervention</th>\n",
       "      <th>comparator</th>\n",
       "      <th>outcome</th>\n",
       "      <th>population</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>NCT02263885</td>\n",
       "      <td>[The proposed study will evaluate the safety, ...</td>\n",
       "      <td>exablate transcranial system</td>\n",
       "      <td>-</td>\n",
       "      <td>adverse events</td>\n",
       "      <td>parkinson, 30 - 99</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>NCT02337725</td>\n",
       "      <td>[The purpose of this study is to evaluate the ...</td>\n",
       "      <td>tvp 1012</td>\n",
       "      <td>placebo</td>\n",
       "      <td>change from baseline in movement disorder soci...</td>\n",
       "      <td>parkinson, 30 - 80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>NCT02337738</td>\n",
       "      <td>[The purpose of this study is to evaluate the ...</td>\n",
       "      <td>tvp 1012 1 mg 0 5 mg</td>\n",
       "      <td>placebo</td>\n",
       "      <td>change from baseline in mean daily off-time du...</td>\n",
       "      <td>parkinson, 30 - 79</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>NCT02337751</td>\n",
       "      <td>[The purpose of this study is to evaluate the ...</td>\n",
       "      <td>tvp 1012</td>\n",
       "      <td>placebo</td>\n",
       "      <td>number of participants who experience at least...</td>\n",
       "      <td>parkinson, 30 - 79</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>NCT02337764</td>\n",
       "      <td>[The purpose of this study is to evaluate long...</td>\n",
       "      <td>tvp 1012</td>\n",
       "      <td>-</td>\n",
       "      <td>number of participants who experience at least...</td>\n",
       "      <td>parkinson, 30 - 79</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05635461</td>\n",
       "      <td>[This is a Randomized, Open-Label, Single Oral...</td>\n",
       "      <td>cvn424</td>\n",
       "      <td>suspension (fasted): 150 milligrams (mg) of cv...</td>\n",
       "      <td>area under the concentration-time curve from t...</td>\n",
       "      <td>healthy, 18 - 55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05655377</td>\n",
       "      <td>[The investigators will run an at-home usabili...</td>\n",
       "      <td>exercise using the motion sensing devices</td>\n",
       "      <td>-</td>\n",
       "      <td>number of participants who were successfully a...</td>\n",
       "      <td>parkinson, 18 - 99</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05756075</td>\n",
       "      <td>[The aim of this study is to investigate wheth...</td>\n",
       "      <td>participants will follow a personalized aerobi...</td>\n",
       "      <td>-</td>\n",
       "      <td>mean difference in distance walked during 6mwt</td>\n",
       "      <td>parkinson, 18 - 99</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT05940077</td>\n",
       "      <td>[Parkinson's disease (PD) affects approximatel...</td>\n",
       "      <td>community based exercise involving non contact...</td>\n",
       "      <td>-</td>\n",
       "      <td>number of falls experienced during the study p...</td>\n",
       "      <td>parkinson, 30 - 99</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT05987540</td>\n",
       "      <td>[The purpose of this single arm study is to ev...</td>\n",
       "      <td>non invasive brainstem stimulation</td>\n",
       "      <td>-</td>\n",
       "      <td>mds-updrs (sum of parts i, ii &amp; iii), feasibil...</td>\n",
       "      <td>parkinson, 50 - 99</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>195 rows  6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          doc_id                                            summary  \\\n",
       "192  NCT02263885  [The proposed study will evaluate the safety, ...   \n",
       "188  NCT02337725  [The purpose of this study is to evaluate the ...   \n",
       "190  NCT02337738  [The purpose of this study is to evaluate the ...   \n",
       "191  NCT02337751  [The purpose of this study is to evaluate the ...   \n",
       "189  NCT02337764  [The purpose of this study is to evaluate long...   \n",
       "..           ...                                                ...   \n",
       "4    NCT05635461  [This is a Randomized, Open-Label, Single Oral...   \n",
       "3    NCT05655377  [The investigators will run an at-home usabili...   \n",
       "2    NCT05756075  [The aim of this study is to investigate wheth...   \n",
       "1    NCT05940077  [Parkinson's disease (PD) affects approximatel...   \n",
       "0    NCT05987540  [The purpose of this single arm study is to ev...   \n",
       "\n",
       "                                          intervention  \\\n",
       "192                       exablate transcranial system   \n",
       "188                                           tvp 1012   \n",
       "190                               tvp 1012 1 mg 0 5 mg   \n",
       "191                                           tvp 1012   \n",
       "189                                           tvp 1012   \n",
       "..                                                 ...   \n",
       "4                                               cvn424   \n",
       "3            exercise using the motion sensing devices   \n",
       "2    participants will follow a personalized aerobi...   \n",
       "1    community based exercise involving non contact...   \n",
       "0                   non invasive brainstem stimulation   \n",
       "\n",
       "                                            comparator  \\\n",
       "192                                                  -   \n",
       "188                                            placebo   \n",
       "190                                            placebo   \n",
       "191                                            placebo   \n",
       "189                                                  -   \n",
       "..                                                 ...   \n",
       "4    suspension (fasted): 150 milligrams (mg) of cv...   \n",
       "3                                                    -   \n",
       "2                                                    -   \n",
       "1                                                    -   \n",
       "0                                                    -   \n",
       "\n",
       "                                               outcome          population  \n",
       "192                                     adverse events  parkinson, 30 - 99  \n",
       "188  change from baseline in movement disorder soci...  parkinson, 30 - 80  \n",
       "190  change from baseline in mean daily off-time du...  parkinson, 30 - 79  \n",
       "191  number of participants who experience at least...  parkinson, 30 - 79  \n",
       "189  number of participants who experience at least...  parkinson, 30 - 79  \n",
       "..                                                 ...                 ...  \n",
       "4    area under the concentration-time curve from t...    healthy, 18 - 55  \n",
       "3    number of participants who were successfully a...  parkinson, 18 - 99  \n",
       "2       mean difference in distance walked during 6mwt  parkinson, 18 - 99  \n",
       "1    number of falls experienced during the study p...  parkinson, 30 - 99  \n",
       "0    mds-updrs (sum of parts i, ii & iii), feasibil...  parkinson, 50 - 99  \n",
       "\n",
       "[195 rows x 6 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load GOLD-standard results\n",
    "df_gold = load_trials_json(filepath = DATA_DIR, filename ='supergoldset_standard.json')\n",
    "for col in [\"population\", \"intervention\",\"comparator\", \"outcome\"]:\n",
    "    df_gold[col] = df_gold[col].apply(\n",
    "        lambda x: '; '.join(str(e) for e in x) if isinstance(x, list) else x\n",
    "    )\n",
    "    # set to lowercase (to align with automatic extraction)\n",
    "    df_gold[col] = df_gold[col].str.lower()\n",
    "df_gold.sort_values(by=['doc_id'], inplace=True)\n",
    "df_gold[\"intervention\"] = df_gold[\"intervention\"].apply(normalize_intervention)\n",
    "df_gold"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "abe77d1f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation for BioELECTRA-PICO:\n",
      "                                     precision    recall        f1      bleu  \\\n",
      "element                                                                        \n",
      "population                            0.108997  0.639031  0.170145       NaN   \n",
      "intervention                          0.496695  0.664669  0.491908       NaN   \n",
      "comparator                            0.292308  0.277051  0.279772       NaN   \n",
      "outcome                               0.279303  0.210126  0.176268       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "\n",
      "                                     proportion  total_seconds  \\\n",
      "element                                                          \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT         0.0            NaN   \n",
      "PROCESSING_TIME                             NaN      313.72977   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "\n",
      "                                     avg_seconds_per_doc  \\\n",
      "element                                                    \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 1.617164   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "\n",
      "                                     median_seconds_per_doc  docs_per_minute  \n",
      "element                                                                       \n",
      "population                                              NaN              NaN  \n",
      "intervention                                            NaN              NaN  \n",
      "comparator                                              NaN              NaN  \n",
      "outcome                                                 NaN              NaN  \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN  \n",
      "SUMMARY_BLEU                                            NaN              NaN  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN  \n",
      "PROCESSING_TIME                                    1.346074              NaN  \n",
      "BATCH_THROUGHPUT                                        NaN        37.101994  \n",
      "Evaluation for nlpie_compact_biobert_PICO:\n",
      "                                     precision    recall        f1      bleu  \\\n",
      "element                                                                        \n",
      "population                            0.190313  0.267257  0.203416       NaN   \n",
      "intervention                          0.362573  0.721012  0.410263       NaN   \n",
      "comparator                            0.353846  0.327479  0.333203       NaN   \n",
      "outcome                               0.959054  0.990897  0.965992       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "\n",
      "                                     proportion  total_seconds  \\\n",
      "element                                                          \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT    0.005128            NaN   \n",
      "PROCESSING_TIME                             NaN     110.756346   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "\n",
      "                                     avg_seconds_per_doc  \\\n",
      "element                                                    \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 0.570909   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "\n",
      "                                     median_seconds_per_doc  docs_per_minute  \n",
      "element                                                                       \n",
      "population                                              NaN              NaN  \n",
      "intervention                                            NaN              NaN  \n",
      "comparator                                              NaN              NaN  \n",
      "outcome                                                 NaN              NaN  \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN  \n",
      "SUMMARY_BLEU                                            NaN              NaN  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN  \n",
      "PROCESSING_TIME                                     0.39107              NaN  \n",
      "BATCH_THROUGHPUT                                        NaN       105.095558  \n",
      "Evaluation for nlpie_bio-mobilebert_PICO:\n",
      "                                     precision    recall        f1      bleu  \\\n",
      "element                                                                        \n",
      "population                            0.165114  0.241473  0.176277       NaN   \n",
      "intervention                          0.375585  0.709767  0.424352       NaN   \n",
      "comparator                            0.353846  0.327479  0.333203       NaN   \n",
      "outcome                               0.959054  0.990897  0.965992       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "\n",
      "                                     proportion  total_seconds  \\\n",
      "element                                                          \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT         0.0            NaN   \n",
      "PROCESSING_TIME                             NaN      79.742049   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "\n",
      "                                     avg_seconds_per_doc  \\\n",
      "element                                                    \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 0.411041   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "\n",
      "                                     median_seconds_per_doc  docs_per_minute  \n",
      "element                                                                       \n",
      "population                                              NaN              NaN  \n",
      "intervention                                            NaN              NaN  \n",
      "comparator                                              NaN              NaN  \n",
      "outcome                                                 NaN              NaN  \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN  \n",
      "SUMMARY_BLEU                                            NaN              NaN  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN  \n",
      "PROCESSING_TIME                                    0.296978              NaN  \n",
      "BATCH_THROUGHPUT                                        NaN       145.970666  \n",
      "Evaluation for dmis-lab_biobert-v1.1:\n",
      "                                     precision    recall        f1      bleu  \\\n",
      "element                                                                        \n",
      "population                            0.182338  0.270818  0.200089       NaN   \n",
      "intervention                          0.366933  0.730363  0.421290       NaN   \n",
      "comparator                            0.353846  0.327479  0.333203       NaN   \n",
      "outcome                               0.959054  0.990897  0.965992       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "\n",
      "                                     proportion  total_seconds  \\\n",
      "element                                                          \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT         0.0            NaN   \n",
      "PROCESSING_TIME                             NaN     217.889578   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "\n",
      "                                     avg_seconds_per_doc  \\\n",
      "element                                                    \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 1.123142   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "\n",
      "                                     median_seconds_per_doc  docs_per_minute  \n",
      "element                                                                       \n",
      "population                                              NaN              NaN  \n",
      "intervention                                            NaN              NaN  \n",
      "comparator                                              NaN              NaN  \n",
      "outcome                                                 NaN              NaN  \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN  \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN  \n",
      "SUMMARY_BLEU                                            NaN              NaN  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN  \n",
      "PROCESSING_TIME                                    0.717979              NaN  \n",
      "BATCH_THROUGHPUT                                        NaN        53.421555  \n"
     ]
    }
   ],
   "source": [
    "pico_cols = [\"population\", \"intervention\", \"comparator\", \"outcome\"]\n",
    "evaluation_tables = {}\n",
    "\n",
    "for model_name, pred_df in ner_results_dict.items():\n",
    "    # Measure processing time and throughput for each model\n",
    "    if model_name == \"BioELECTRA-PICO\":\n",
    "        # For Huggingface pipeline\n",
    "        total_time, avg_time, median_time = measure_processing_time(process_trials_for_PICO, mydf_manual_annotation, ner_pipeline_hf)\n",
    "    else:\n",
    "        # For custom models\n",
    "        # Find the corresponding pipeline by model_name if needed\n",
    "        pipeline_idx = model_names.index(model_name)\n",
    "        ner_pipeline = ner_pipelines[pipeline_idx - 1]  # -1 because HF is first\n",
    "        total_time, avg_time, median_time = measure_processing_time(process_trials_for_retrained_PICO, mydf_manual_annotation, ner_pipeline)\n",
    "    throughput = calculate_batch_throughput(total_time, len(mydf_manual_annotation))\n",
    "\n",
    "    _, evaluation_table = evaluate_ner_model_partial_overlap(\n",
    "        df_gold,\n",
    "        pred_df,\n",
    "        pico_cols,\n",
    "        summary_gold_col='summary',\n",
    "        summary_pred_col='summary',\n",
    "        add_rouge=True,\n",
    "        processing_time=(total_time, avg_time, median_time),\n",
    "        batch_throughput=throughput\n",
    "    )\n",
    "    evaluation_tables[model_name] = evaluation_table\n",
    "\n",
    "# print all evaluation tables\n",
    "for name, table in evaluation_tables.items():\n",
    "    print(f\"Evaluation for {name}:\")\n",
    "    print(table)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fc41df80",
   "metadata": {},
   "source": [
    "# **Comparison of BERT-based PICO NER Models**\n",
    "\n",
    "## **1. Population**\n",
    "\n",
    "- **Precision/Recall/F1:**\n",
    "  - All models report low F1 (0.170.20) for population. **BioELECTRA-PICO** is the lowest (F1 = 0.17) due to very low precision (0.11); the other three (nlpie_compact_biobert, nlpie_bio-mobilebert, dmis-lab_biobert-v1.1) are slightly higher (F1 = 0.180.20) with marginally better but still modest precision.\n",
    "  - **Recall** is highest for BioELECTRA-PICO (0.64), but this comes at the cost of large numbers of false positives (precision 0.11).\n",
    "- **Interpretation:**  \n",
    "  No model achieves high or even moderate performancepopulation extraction remains a challenge. Slight edge to *dmis-lab_biobert-v1.1* (F1 = 0.20), but the difference is small.\n",
    "\n",
    "---\n",
    "\n",
    "## **2. Intervention**\n",
    "\n",
    "- **Precision/Recall/F1:**\n",
    "  - F1 is highest for **BioELECTRA-PICO** (0.49), thanks to strong recall (0.66) and acceptable precision (0.50).\n",
    "  - All BERT-derived models (nlpie_compact_biobert, nlpie_bio-mobilebert, dmis-lab_biobert-v1.1) have similar F1 (~0.410.42), characterized by high recall (0.710.73) but moderate precision (0.360.38).\n",
    "- **Interpretation:**  \n",
    "  BioELECTRA-PICO extracts more interventions, with somewhat better balance, while BERT-based models are more conservative but similarly accurate.\n",
    "\n",
    "---\n",
    "\n",
    "## **3. Comparator**\n",
    "\n",
    "- **Precision/Recall/F1:**\n",
    "  - All models produce identical results (Precision: 0.35, Recall: 0.33, F1: 0.33).\n",
    "- **Interpretation:**  \n",
    "  Scores are set by evaluation data or a fixed pipeline, so comparator cannot be used to distinguish models.\n",
    "\n",
    "---\n",
    "\n",
    "## **4. Outcome**\n",
    "\n",
    "- **Precision/Recall/F1:**\n",
    "  - All BERT-based models (nlpie_compact_biobert, nlpie_bio-mobilebert, dmis-lab_biobert-v1.1) achieve extremely high outcome extraction (Precision: 0.96, Recall: 0.99, F1: 0.97).\n",
    "  - By contrast, **BioELECTRA-PICO** underperforms (F1 = 0.18, Precision: 0.28, Recall: 0.21).\n",
    "- **Interpretation:**  \n",
    "  BERT-based models are highly reliable for outcome NER, while BioELECTRA-PICO is relatively poor.\n",
    "\n",
    "---\n",
    "\n",
    "## **5. Summarization Quality (ROUGE/BLEU)**\n",
    "\n",
    "- evaluation not applicable, as summary is generated by TextRank, not by the NER model.\n",
    "\n",
    "---\n",
    "\n",
    "## **6. Processing Speed**\n",
    "\n",
    "| Model                             | Median sec/doc | Docs/minute  |\n",
    "|-----------------------------------|---------------:|-------------:|\n",
    "| nlpie_bio-mobilebert              |         0.30   |       146    |\n",
    "| nlpie_compact_biobert             |         0.39   |       105    |\n",
    "| dmis-lab_biobert-v1.1             |         0.72   |        53    |\n",
    "| BioELECTRA-PICO                   |         1.35   |        37    |\n",
    "\n",
    "- **Interpretation:**  \n",
    "  *nlpie_bio-mobilebert* is the fastest by a wide margin. BioELECTRA-PICO is slowest.\n",
    "\n",
    "---\n",
    "\n",
    "## **Strengths and Weaknesses**\n",
    "\n",
    "| Model                    | Strengths                       | Weaknesses                                   |\n",
    "|--------------------------|---------------------------------|-----------------------------------------------|\n",
    "| **BioELECTRA-PICO**      | Best intervention F1; high recall | Very low population and outcome F1; slowest   |\n",
    "| **nlpie_compact_biobert**| Best outcome extraction; fast    | Population/intervention F1 only moderate      |\n",
    "| **nlpie_bio-mobilebert** | Strong outcome; fastest         | Population/intervention F1 moderate           |\n",
    "| **dmis-lab_biobert-v1.1**| Strongest all-round on BERT lines| Slowest BERT model; still weak population F1  |\n",
    "\n",
    "---\n",
    "\n",
    "## **Guidance for Use**\n",
    "\n",
    "- **For highest-quality outcome extraction:** *Any of the three BERT-based models* (not BioELECTRA) will give highly accurate results.\n",
    "- **For most balanced intervention extraction:** *BioELECTRA-PICO* performs best, but at the cost of population/outcome accuracy and slow speed.\n",
    "- **For large-scale/fast batch processing:** *nlpie_bio-mobilebert* is by far the fastest.\n",
    "- **Population extraction:** All models struggle; no model achieves robust accuracy.\n",
    "- **Comparator:** Not informative for model selection.\n",
    "\n",
    "---\n",
    "\n",
    "## **Best-by-Metric Table**\n",
    "\n",
    "| PICO Element   | Top Model            | Notes                        |\n",
    "|----------------|---------------------|------------------------------|\n",
    "| Population     | dmis-lab_biobert-v1.1| F1 = 0.20 (all poor overall) |\n",
    "| Intervention   | BioELECTRA-PICO     | F1 = 0.49                    |\n",
    "| Outcome        | BERT-based models   | F1 = 0.97 (BioELECTRA poor)  |\n",
    "| Processing Speed | nlpie_bio-mobilebert | ~0.3s/doc, 146 docs/min     |\n",
    "\n",
    "---\n",
    "\n",
    "## **Final Recommendation**\n",
    "\n",
    "- **For outcome extraction:** Use any BERT-based model (*nlpie_compact_biobert*, *nlpie_bio-mobilebert*, or *dmis-lab_biobert*). They are equally accurate.\n",
    "- **If intervention extraction matters most:** *BioELECTRA-PICO* offers a modest F1 advantage but is slower and weak elsewhere.\n",
    "- **If fast, large-scale throughput is crucial:** *nlpie_bio-mobilebert* is the clear winner.\n",
    "- **Weaknesses:** Population extraction is a common limitationusers should not rely on any model here for high-fidelity population NER.\n",
    "\n",
    "**Summary:**  \n",
    "For reliable PICO extraction, especially outcomes, BERT-based models remain most dependable. BioELECTRA-PICO is only recommended if you specifically want greater recall on interventions and accept slower runtime and poor population/outcome tagging.\n",
    "\n",
    "(Comparator metric is not recommended for model selection, as noted.)\n",
    "\n",
    "**(Comparator extraction scores cannot be used for model selection in this context.)**\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "1a8a4375",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Evaluation for BioELECTRA-PICO:\n",
      "Evaluation for nlpie_compact_biobert_PICO:\n",
      "Evaluation for nlpie_bio-mobilebert_PICO:\n",
      "Evaluation for dmis-lab_biobert-v1.1:\n",
      "                                     precision    recall        f1      bleu  \\\n",
      "element                                                                        \n",
      "population                            0.108997  0.639031  0.170145       NaN   \n",
      "intervention                          0.496695  0.664669  0.491908       NaN   \n",
      "comparator                            0.292308  0.277051  0.279772       NaN   \n",
      "outcome                               0.279303  0.210126  0.176268       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "population                            0.190313  0.267257  0.203416       NaN   \n",
      "intervention                          0.362573  0.721012  0.410263       NaN   \n",
      "comparator                            0.353846  0.327479  0.333203       NaN   \n",
      "outcome                               0.959054  0.990897  0.965992       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "population                            0.165114  0.241473  0.176277       NaN   \n",
      "intervention                          0.375585  0.709767  0.424352       NaN   \n",
      "comparator                            0.353846  0.327479  0.333203       NaN   \n",
      "outcome                               0.959054  0.990897  0.965992       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "population                            0.182338  0.270818  0.200089       NaN   \n",
      "intervention                          0.366933  0.730363  0.421290       NaN   \n",
      "comparator                            0.353846  0.327479  0.333203       NaN   \n",
      "outcome                               0.959054  0.990897  0.965992       NaN   \n",
      "SUMMARY_ROUGE-1                       0.590636  0.661871  0.564032       NaN   \n",
      "SUMMARY_ROUGE-2                       0.494957  0.557964  0.474780       NaN   \n",
      "SUMMARY_ROUGE-L                       0.533758  0.607488  0.515064       NaN   \n",
      "SUMMARY_BLEU                               NaN       NaN       NaN  0.344077   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT        NaN       NaN       NaN       NaN   \n",
      "PROCESSING_TIME                            NaN       NaN       NaN       NaN   \n",
      "BATCH_THROUGHPUT                           NaN       NaN       NaN       NaN   \n",
      "\n",
      "                                     proportion  total_seconds  \\\n",
      "element                                                          \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT    0.000000            NaN   \n",
      "PROCESSING_TIME                             NaN     313.729770   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT    0.005128            NaN   \n",
      "PROCESSING_TIME                             NaN     110.756346   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT    0.000000            NaN   \n",
      "PROCESSING_TIME                             NaN      79.742049   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "population                                  NaN            NaN   \n",
      "intervention                                NaN            NaN   \n",
      "comparator                                  NaN            NaN   \n",
      "outcome                                     NaN            NaN   \n",
      "SUMMARY_ROUGE-1                             NaN            NaN   \n",
      "SUMMARY_ROUGE-2                             NaN            NaN   \n",
      "SUMMARY_ROUGE-L                             NaN            NaN   \n",
      "SUMMARY_BLEU                                NaN            NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT    0.000000            NaN   \n",
      "PROCESSING_TIME                             NaN     217.889578   \n",
      "BATCH_THROUGHPUT                            NaN            NaN   \n",
      "\n",
      "                                     avg_seconds_per_doc  \\\n",
      "element                                                    \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 1.617164   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 0.570909   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 0.411041   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "population                                           NaN   \n",
      "intervention                                         NaN   \n",
      "comparator                                           NaN   \n",
      "outcome                                              NaN   \n",
      "SUMMARY_ROUGE-1                                      NaN   \n",
      "SUMMARY_ROUGE-2                                      NaN   \n",
      "SUMMARY_ROUGE-L                                      NaN   \n",
      "SUMMARY_BLEU                                         NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                  NaN   \n",
      "PROCESSING_TIME                                 1.123142   \n",
      "BATCH_THROUGHPUT                                     NaN   \n",
      "\n",
      "                                     median_seconds_per_doc  docs_per_minute  \\\n",
      "element                                                                        \n",
      "population                                              NaN              NaN   \n",
      "intervention                                            NaN              NaN   \n",
      "comparator                                              NaN              NaN   \n",
      "outcome                                                 NaN              NaN   \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN   \n",
      "SUMMARY_BLEU                                            NaN              NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN   \n",
      "PROCESSING_TIME                                    1.346074              NaN   \n",
      "BATCH_THROUGHPUT                                        NaN        37.101994   \n",
      "population                                              NaN              NaN   \n",
      "intervention                                            NaN              NaN   \n",
      "comparator                                              NaN              NaN   \n",
      "outcome                                                 NaN              NaN   \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN   \n",
      "SUMMARY_BLEU                                            NaN              NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN   \n",
      "PROCESSING_TIME                                    0.391070              NaN   \n",
      "BATCH_THROUGHPUT                                        NaN       105.095558   \n",
      "population                                              NaN              NaN   \n",
      "intervention                                            NaN              NaN   \n",
      "comparator                                              NaN              NaN   \n",
      "outcome                                                 NaN              NaN   \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN   \n",
      "SUMMARY_BLEU                                            NaN              NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN   \n",
      "PROCESSING_TIME                                    0.296978              NaN   \n",
      "BATCH_THROUGHPUT                                        NaN       145.970666   \n",
      "population                                              NaN              NaN   \n",
      "intervention                                            NaN              NaN   \n",
      "comparator                                              NaN              NaN   \n",
      "outcome                                                 NaN              NaN   \n",
      "SUMMARY_ROUGE-1                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-2                                         NaN              NaN   \n",
      "SUMMARY_ROUGE-L                                         NaN              NaN   \n",
      "SUMMARY_BLEU                                            NaN              NaN   \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT                     NaN              NaN   \n",
      "PROCESSING_TIME                                    0.717979              NaN   \n",
      "BATCH_THROUGHPUT                                        NaN        53.421555   \n",
      "\n",
      "                                                          model  \n",
      "element                                                          \n",
      "population                                      BioELECTRA-PICO  \n",
      "intervention                                    BioELECTRA-PICO  \n",
      "comparator                                      BioELECTRA-PICO  \n",
      "outcome                                         BioELECTRA-PICO  \n",
      "SUMMARY_ROUGE-1                                 BioELECTRA-PICO  \n",
      "SUMMARY_ROUGE-2                                 BioELECTRA-PICO  \n",
      "SUMMARY_ROUGE-L                                 BioELECTRA-PICO  \n",
      "SUMMARY_BLEU                                    BioELECTRA-PICO  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT             BioELECTRA-PICO  \n",
      "PROCESSING_TIME                                 BioELECTRA-PICO  \n",
      "BATCH_THROUGHPUT                                BioELECTRA-PICO  \n",
      "population                           nlpie_compact_biobert_PICO  \n",
      "intervention                         nlpie_compact_biobert_PICO  \n",
      "comparator                           nlpie_compact_biobert_PICO  \n",
      "outcome                              nlpie_compact_biobert_PICO  \n",
      "SUMMARY_ROUGE-1                      nlpie_compact_biobert_PICO  \n",
      "SUMMARY_ROUGE-2                      nlpie_compact_biobert_PICO  \n",
      "SUMMARY_ROUGE-L                      nlpie_compact_biobert_PICO  \n",
      "SUMMARY_BLEU                         nlpie_compact_biobert_PICO  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT  nlpie_compact_biobert_PICO  \n",
      "PROCESSING_TIME                      nlpie_compact_biobert_PICO  \n",
      "BATCH_THROUGHPUT                     nlpie_compact_biobert_PICO  \n",
      "population                            nlpie_bio-mobilebert_PICO  \n",
      "intervention                          nlpie_bio-mobilebert_PICO  \n",
      "comparator                            nlpie_bio-mobilebert_PICO  \n",
      "outcome                               nlpie_bio-mobilebert_PICO  \n",
      "SUMMARY_ROUGE-1                       nlpie_bio-mobilebert_PICO  \n",
      "SUMMARY_ROUGE-2                       nlpie_bio-mobilebert_PICO  \n",
      "SUMMARY_ROUGE-L                       nlpie_bio-mobilebert_PICO  \n",
      "SUMMARY_BLEU                          nlpie_bio-mobilebert_PICO  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT   nlpie_bio-mobilebert_PICO  \n",
      "PROCESSING_TIME                       nlpie_bio-mobilebert_PICO  \n",
      "BATCH_THROUGHPUT                      nlpie_bio-mobilebert_PICO  \n",
      "population                                dmis-lab_biobert-v1.1  \n",
      "intervention                              dmis-lab_biobert-v1.1  \n",
      "comparator                                dmis-lab_biobert-v1.1  \n",
      "outcome                                   dmis-lab_biobert-v1.1  \n",
      "SUMMARY_ROUGE-1                           dmis-lab_biobert-v1.1  \n",
      "SUMMARY_ROUGE-2                           dmis-lab_biobert-v1.1  \n",
      "SUMMARY_ROUGE-L                           dmis-lab_biobert-v1.1  \n",
      "SUMMARY_BLEU                              dmis-lab_biobert-v1.1  \n",
      "PROPORTION_ALL_PICO_PARTIAL_CORRECT       dmis-lab_biobert-v1.1  \n",
      "PROCESSING_TIME                           dmis-lab_biobert-v1.1  \n",
      "BATCH_THROUGHPUT                          dmis-lab_biobert-v1.1  \n"
     ]
    }
   ],
   "source": [
    "tables_with_model = []\n",
    "for name, table in evaluation_tables.items():\n",
    "    print(f\"Evaluation for {name}:\")\n",
    "    table[\"model\"] = name\n",
    "    tables_with_model.append(table)\n",
    "\n",
    "\n",
    "# Combine all tables into one\n",
    "combined_table = pd.concat(tables_with_model, ignore_index=False)\n",
    "\n",
    "# Display or use the combined table\n",
    "print(combined_table)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "377f7958",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x1500 with 9 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Rename 'element' to 'parameter' for clarity\n",
    "df = combined_table.reset_index().rename(columns={'element': 'parameter'})\n",
    "\n",
    "\n",
    "# List of metric columns to plot\n",
    "metrics = combined_table.columns[0:9]\n",
    "\n",
    "\n",
    "# Set up grid layout for subplots\n",
    "n_cols = 3\n",
    "n_rows = int(np.ceil(len(metrics) / n_cols))\n",
    "fig, axes = plt.subplots(n_rows, n_cols, figsize=(18, 5 * n_rows))\n",
    "axes = axes.flatten()\n",
    "\n",
    "\n",
    "# Plot each metric\n",
    "for i, metric in enumerate(metrics):\n",
    "    ax = axes[i]\n",
    "    pivot_df = df.pivot(index='parameter', columns='model', values=metric)\n",
    "    pivot_df = pivot_df.dropna(how='all')  # Remove rows where all model values are NaN\n",
    "    if not pivot_df.empty:\n",
    "        pivot_df.plot(kind='bar', ax=ax)\n",
    "        ax.set_title(f'Model Comparison by Parameter: {metric}')\n",
    "        ax.set_xlabel('Parameter')\n",
    "        ax.set_ylabel(metric)\n",
    "        ax.legend(title='Model', loc='lower left')\n",
    "        ax.tick_params(axis='x', rotation=45)\n",
    "        #ax.set_facecolor('white')\n",
    "    else:\n",
    "        ax.set_visible(False)\n",
    "\n",
    "# Hide any unused subplots\n",
    "for j in range(i + 1, len(axes)):\n",
    "    fig.delaxes(axes[j])\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "27d6ade2",
   "metadata": {},
   "outputs": [],
   "source": [
    "combined_table.to_csv(\"all model results on supergoldgold.txt\", sep='\\t', decimal=',')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "50499d90",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "nlp",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
